Logo BizupsLogo Bizups
    • Investors
    • Accelerators
    • Incubators
    • Startups

      Investor posts

      • Home
      • Posts
      • Investor
      Lumira Ventures
      Charting A New Course For Chronic Cough Treatment
      • . Oct. 11, 2024, 9:49 p.m.

      Charting A New Course For Chronic Cough Treatment

      Lumira Ventures
      X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
      • . Oct. 11, 2024, 9:49 p.m.

      X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) …

      Lumira Ventures
      X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
      • . Oct. 11, 2024, 9:49 p.m.

      X4 Pharmaceuticals Announces $125 Million Capital Infusion from …

      Lumira Ventures
      AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain
      • . Oct. 11, 2024, 9:49 p.m.

      AmacaThera doses First In Human Study to Evaluate, …

      Lumira Ventures
      Transposon Receives US FDA Fast Track Designation for TPN-101 for Progressive Supranuclear Palsy
      • . Oct. 11, 2024, 9:49 p.m.

      Transposon Receives US FDA Fast Track Designation for …

      Lumira Ventures
      Revolutionizing Pain Management: How AmacaThera is Helping to Combat the Opioid Crisis
      • . Oct. 11, 2024, 9:49 p.m.

      Revolutionizing Pain Management: How AmacaThera is Helping to …

      Lumira Ventures
      Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure 
      • . Oct. 11, 2024, 9:49 p.m.

      Endotronix Receives FDA Premarket Approval of the Cordella™ …

      Lumira Ventures
      Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes
      • . Oct. 11, 2024, 9:49 p.m.

      Endogenex™ Announces $88 Million Series C Financing to …

      Lumira Ventures
      Lumira Ventures Announces Promotion of Nikhil Thatte to Partner
      • . Oct. 11, 2024, 9:49 p.m.

      Lumira Ventures Announces Promotion of Nikhil Thatte to …

      Lumira Ventures
      XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart
      • . Oct. 11, 2024, 9:49 p.m.

      XyloCor Therapeutics and SmartCella Enter into License Agreement …

      Lumira Ventures
      Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
      • . Oct. 11, 2024, 9:49 p.m.

      Nocion Therapeutics Presents Data on Preclinical and Clinical …

      Lumira Ventures
      enGene Announces Appointment of Ron Cooper as Chief Executive Officer
      • . Oct. 11, 2024, 9:49 p.m.

      enGene Announces Appointment of Ron Cooper as Chief …

      Lumira Ventures
      Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
      • . Oct. 11, 2024, 9:49 p.m.

      Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions …

      Lumira Ventures
      Transposon Announces Final Results from a Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
      • . Oct. 11, 2024, 9:49 p.m.

      Transposon Announces Final Results from a Phase 2 …

      Lumira Ventures
      X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) and Initiation of Pivotal Phase 3 CN Trial
      • . Oct. 11, 2024, 9:49 p.m.

      X4 Pharmaceuticals Announces Positive Interim Clinical Data from …

      Lumira Ventures
      COUR Pharmaceuticals Awarded One of Fierce Biotech’s 2024 Fierce 15
      • . Oct. 11, 2024, 9:49 p.m.

      COUR Pharmaceuticals Awarded One of Fierce Biotech’s 2024 …

        • 13
        • 14
        • 15
        • 16
        • 17
        • 18
        • 19
        • 20
        • 21

      Search Posts

      Categories

        Last Posts

          Logo Bizups

          Uncover the Startup Ecosystem

          • Info@bizups.info

          Links

          • Investors
          • Accelerators
          • Incubators
          • Startups

          Links

          • Programs
          • Events
          • Mentors
          • Posts
          • Live

          Support

          • About Us
          • User Guide
          • Disclaimer
          • Privacy Policy
          • Contact Us

          Social Media

          © Bizups.info. All rights reserved.
          Login
          Sign In/Sign Up with linkedin
          Signup

          Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.

          We found a number of people with your first name. When you find your first name in this list, select it

          This section is for the registration of real people's first name, it will be canceled in case of registration with name/organization or startup profile. After registering First name, you can add and manage your startup.Entering all requested information is mandatory